Chronic Myelomonocytic Leukemia Completed Phase 1 Trials for Cefepime (DB01413)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01484015Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile NeutropeniaTreatment